A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens

• Published in: mBio Vol. 9; no. 3
• Main Authors: Litschko, Christa, Oldrini, Davide, Budde, Insa, Berger, Monika, Meens, Jochen, Gerardy-Schahn, Rita, Berti, Francesco, Schubert, Mario, Fiebig, Timm
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 29.05.2018
• Subjects: Bacterial Capsules - chemistry; Bacterial Capsules - metabolism; Bacterial Proteins - chemistry; Bacterial Proteins - genetics; Bacterial Proteins - metabolism; capsular polysaccharide; capsule; enzymatic synthesis; Glycosyltransferases - chemistry; Glycosyltransferases - genetics; Glycosyltransferases - metabolism; Gram-Negative Bacteria - chemistry; Gram-Negative Bacteria - enzymology; Gram-Negative Bacteria - genetics; Gram-Negative Bacteria - metabolism; Multigene Family; nuclear magnetic resonance; Phosphotransferases - chemistry; Phosphotransferases - genetics; Phosphotransferases - metabolism; polymerases; Polymers - chemistry; Polymers - metabolism; TagF; Teichoic Acids - analysis; Teichoic Acids - metabolism; capsule; capsular polysaccharide; enzymatic synthesis; vaccines; veterinary vaccine development; polymerases; teichoic acids; TagF; polymers; Actinobacillus pleuropneumoniae; nuclear magnetic resonance; Haemophilus influenzae
• ISSN: 2161-2129; 2150-7511
• DOI: 10.1128/mBio.00641-18

Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferase activity to generate complex poly(oligosaccharide phosphate) and poly(glycosylpolyol phosphate) polymers, the latter of which display similarity to wall teichoic acid (WTA), a cell wall component of Gram-positive bacteria. Using modeling and multiple-sequence alignment, we showed homology between the predicted polymerase domains and WTA type I biosynthesis enzymes, creating a link between Gram-negative and Gram-positive cell wall biosynthesis processes. The polymerases of the new family are highly abundant and found in a variety of capsule-expressing pathogens such as , , , , and with both human and animal hosts. Five representative candidates were purified, their activities were confirmed using nuclear magnetic resonance (NMR) spectroscopy, and their predicted folds were validated by site-directed mutagenesis. Bacterial capsules play an important role in the interaction between a pathogen and the immune system of its host. During the last decade, capsule polymerases have become attractive tools for the production of capsule polymers applied as antigens in glycoconjugate vaccine formulations. Conventional production of glycoconjugate vaccines requires the cultivation of the pathogen and thus the highest biosafety standards, leading to tremendous costs. With regard to animal husbandry, where vaccines could avoid the extensive use of antibiotics, conventional production is not sufficiently cost-effective. In contrast, enzymatic synthesis of capsule polymers is pathogen-free and fast, offers high stereo- and regioselectivity, and works with high efficacy. The new capsule polymerase family described here vastly increases the toolbox of enzymes available for biotechnology purposes. Representatives are abundantly found in human pathogens but also in animal pathogens, paving the way for the exploitation of polymerases for the development of a new generation of vaccines for animal husbandry.